The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers

ISSN： 1389-9600

Source： Familial Cancer, Vol.9, Iss.4, 2010-12, pp. : 545-553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

By Kotsopoulos Joanne

Cancer Causes and Control, Vol. 16, Iss. 6, 2005-08 ,pp. : 667-674

Springer Publishing Company

Access to resources Recommend Favorite

Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers

By Bernholtz Shiri

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 981-985

Springer Publishing Company

Access to resources Recommend Favorite

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers

By Catucci Irene

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 855-860

Springer Publishing Company

Access to resources Recommend Favorite